T Kerby
Overview
Explore the profile of T Kerby including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
850
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rolnick S, Parker E, Nordin J, Hedblom B, Wei F, Kerby T, et al.
Vaccine
. 2013 Jun;
31(37):3928-35.
PMID: 23806243
Immunizations are crucial to the prevention of disease, thus, having an accurate measure of vaccination status for a population is an important guide in targeting prevention efforts. In order to...
2.
Moghrabi A, Friedman H, Ashley D, Bottom K, Kerby T, Stewart E, et al.
Neurosurg Focus
. 2006 Dec;
4(4):e3.
PMID: 17168503
In this study, the authors sought to investigate the response rate and toxicity of carboplatin in patients with progressive low-grade glioma (LGG). Thirty-two patients with progressive LGG were treated with...
3.
Friedman H, Kerby T, Calvert H
Clin Cancer Res
. 2000 Jul;
6(7):2585-97.
PMID: 10914698
Malignant gliomas (glioblastoma multiforme and anaplastic astrocytoma) occur more frequently than other types of primary central nervous system tumors, having a combined incidence of 5-8/100,000 population. Even with aggressive treatment...
4.
Friedman H, Petros W, Friedman A, Schaaf L, Kerby T, Lawyer J, et al.
J Clin Oncol
. 1999 May;
17(5):1516-25.
PMID: 10334539
Purpose: To determine the activity, toxicity, and pharmacokinetics of irinotecan (CPT-11, Camptosar; Pharmacia & Upjohn, Kalamazoo, MI) in the treatment of adults with progressive, persistent, or recurrent malignant glioma. Patients...
5.
Friedman H, Kerby T, Fields S, Zilisch J, Graden D, McLendon R, et al.
Cancer
. 1999 Mar;
85(5):1160-5.
PMID: 10091802
Background: Topotecan activity was evaluated for the treatment of malignant glioma. Methods: Sixty-three patients with newly diagnosed (n = 25) or recurrent (n = 38) malignant glioma were treated with...
6.
Friedman H, McLendon R, Kerby T, Dugan M, Bigner S, HENRY A, et al.
J Clin Oncol
. 1998 Dec;
16(12):3851-7.
PMID: 9850030
Purpose: We evaluated the response to Temodal (Schering-Plough Research Institute, Kenilworth, NJ) of patients with newly diagnosed malignant glioma, as well as the predictive value of quantifying tumor DNA mismatch...
7.
Friedman H, Kokkinakis D, Pluda J, Friedman A, Cokgor I, Haglund M, et al.
J Clin Oncol
. 1998 Nov;
16(11):3570-5.
PMID: 9817277
Purpose: The major mechanism of resistance to alkylnitrosourea therapy is the DNA repair protein O6-alkylguanine-DNA alkyltransferase (AGT), which removes chlorethylation or methylation damage from the O6-position of guanine. O6-benzylguanine (O6-BG)...
8.
McCowage G, Friedman H, Moghrabi A, Kerby T, Ferrell L, Stewart E, et al.
Med Pediatr Oncol
. 1997 Dec;
30(2):75-80.
PMID: 9403013
Seventeen patients less than or equal to 20 years of age with newly diagnosed (n = 10) or recurrent (n = 7) malignant gliomas (anaplastic astrocytoma and glioblastoma multiforme) were...
9.
Knauth M, Ries S, Pohimann S, Kerby T, Forsting M, Daffertshofer M, et al.
BMJ
. 1997 Mar;
314(7082):701-5.
PMID: 9116544
Objective: To investigate the role of a patient foramen ovale in the pathogenesis of multiple brain lesions acquired by sport divers in the absence of reported decompression symptoms. Design: Prospective...
10.
McCowage G, Tien R, McLendon R, Felsberg G, Fuchs H, Graham M, et al.
Med Pediatr Oncol
. 1996 Jul;
27(1):32-9.
PMID: 8614389
Leptomeningeal dissemination of childhood pilocytic astrocytoma (PA) is a rare event with little information available regarding therapy. We report here four children with disseminated PA whom we treated with high...